NEW YORK, NY / ACCESS Newswire / March 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply securities prior to May 6, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/XRAY.
Dublin, March 11, 2025 (GLOBE NEWSWIRE) -- The "Dental Sterilization Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables and Accessories), By End Use (Hospitals, Dental Clinics, Dental Laboratories), By Region, And Segment Forecasts, 2025 - 2030" report has been added to ResearchAndMarkets.com's offering. The global dental sterilization market size is expected to reach USD 2.69 billion by 2030, expanding at a CAGR of 8.8% from 2025 to 2030. Increasing prevalence of dental conditions, growing number of dental care personnel, and rising number of dental facilities are anticipated to drive the market. A rising number of dental surgical procedures and increasing efforts to infection control and prevent cross-infection by instruments are stimulating the growth of the market. Market players are also continuously involved in introducing new products, which is expected to positively influence the growth of the market. For instance, the introduction of AdvantaClear surface disinfectant by Hu-Friedy, which kills pathogens in one-minute. Key players operating in the market are using different strategies such as new product development, acquisitions, partnerships, joint ventures, and agreements to strengthen their foothold in the market space. Moreover, the dental sterilization market in developed economies, such as U.S., Germany, France, and Australia, is comparatively mature owing to the domicile of several key market players belonging to these countries and high demand for such products among end users. On the other hand, developing Asian and Latin American countries, currently, have a moderate adoption of these products. Economic growth and rising disposable income in these countries are likely to propel the market. Manufacturing companies are investing in these rapidly developing markets in order to tap into the potential, provided pricing and distribution activities are undertaken efficiently. Dental Sterilization Market Report Highlights
Look into Dentsply's (XRAY) global revenue patterns and how these figures influence Wall Street's predictions and the future of the stock.
NEW YORK, NY / ACCESS Newswire / March 2, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply securities prior to May 6, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/XRAY.
DENTSPLY SIRONA's fourth-quarter results showcase dismal segmental performance with declining adjusted operating income.
Dentsply International (XRAY) came out with quarterly earnings of $0.26 per share, missing the Zacks Consensus Estimate of $0.43 per share. This compares to earnings of $0.44 per share a year ago.
CHARLOTTE, N.C., Feb. 27, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) today announced its financial results for the fourth quarter and full year of 2024.
Evaluate the expected performance of Dentsply (XRAY) for the quarter ended December 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
XRAY is likely to have faced a tough fourth quarter with Byte's revenue loss, weak U.S. equipment demand and implant pressures.
NEW YORK, NY / ACCESS Newswire / February 19, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply securities prior to May 6, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/XRAY.